Corbus Pharmaceuticals Holdings (CRBP) Short-term Investments (2020 - 2025)

Corbus Pharmaceuticals Holdings' Short-term Investments history runs 6 years deep, the most recent figure standing at $670000.0 for Q4 2025.

• On a quarterly basis, Short-term Investments rose 135.09% year-over-year to $670000.0 in Q4 2025; TTM through Dec 2025 was $670000.0, a 135.09% increase from a year earlier, with the FY2025 full-year figure at $670000.0, up 135.09% from the prior year.
• Short-term Investments climbed to $670000.0 in Q4 2025 per CRBP's latest filing, from $285000.0 in the prior quarter.
• Across five years, Short-term Investments topped out at $139.9 million in Q3 2024 and bottomed at $192475.0 in Q4 2021.
• The 5-year median for Short-term Investments is $35.6 million (2022), against an average of $43.2 million.
• Across the five-year window, Short-term Investments soared 72605.03% in 2024 and plunged 99.8% in 2025, its largest moves.
• Year by year, Short-term Investments stood at $192475.0 in 2021, then soared by 21821.96% to $42.2 million in 2022, then tumbled by 82.98% to $7.2 million in 2023, then plunged by 96.03% to $285000.0 in 2024, then soared by 135.09% to $670000.0 in 2025.
• Per Business Quant, the three latest CRBP Short-term Investments figures stand at $670000.0 (Q4 2025), $285000.0 (Q3 2025), and $96.5 million (Q2 2025).